LinkedIn Profile

Access Celldex Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:cldx 597166 Apr 21st, 2024 12:00AM Celldex Therapeutics 9.8K 195.00 Open Apr 20th, 2024 11:13PM Apr 20th, 2024 11:13PM Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Open Immuno-oncology, Therapeutic antibodies, Immune system modulators, Immunotherapies, Oncology, Inflammatory Diseases, Inflammation, and Urticaria Open 53 Frontage Road Hampton NJ US 08827 Celldex Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:cldx 597166 Apr 20th, 2024 12:00AM Celldex Therapeutics 9.8K 195.00 Open Apr 19th, 2024 11:10PM Apr 20th, 2024 04:46PM Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Open Immuno-oncology, Therapeutic antibodies, Immune system modulators, Immunotherapies, Oncology, Inflammatory Diseases, Inflammation, and Urticaria Open 53 Frontage Road Hampton NJ US 08827 Celldex Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:cldx 597166 Apr 19th, 2024 12:00AM Celldex Therapeutics 9.8K 195.00 Open Apr 18th, 2024 11:17PM Apr 18th, 2024 11:17PM Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Open Immuno-oncology, Therapeutic antibodies, Immune system modulators, Immunotherapies, Oncology, Inflammatory Diseases, Inflammation, and Urticaria Open 53 Frontage Road Hampton NJ US 08827 Celldex Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:cldx 597166 Apr 18th, 2024 12:00AM Celldex Therapeutics 9.8K 195.00 Open Apr 17th, 2024 11:16PM Apr 18th, 2024 06:06PM Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Open Immuno-oncology, Therapeutic antibodies, Immune system modulators, Immunotherapies, Oncology, Inflammatory Diseases, Inflammation, and Urticaria Open 53 Frontage Road Hampton NJ US 08827 Celldex Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:cldx 597166 Apr 17th, 2024 12:00AM Celldex Therapeutics 9.7K 195.00 Open Apr 16th, 2024 11:07PM Apr 17th, 2024 02:30PM Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Open Immuno-oncology, Therapeutic antibodies, Immune system modulators, Immunotherapies, Oncology, Inflammatory Diseases, Inflammation, and Urticaria Open 53 Frontage Road Hampton NJ US 08827 Celldex Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:cldx 597166 Apr 16th, 2024 12:00AM Celldex Therapeutics 9.7K 195.00 Open Apr 15th, 2024 11:01PM Apr 16th, 2024 10:46AM Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Open Immuno-oncology, Therapeutic antibodies, Immune system modulators, Immunotherapies, Oncology, Inflammatory Diseases, Inflammation, and Urticaria Open 53 Frontage Road Hampton NJ US 08827 Celldex Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:cldx 597166 Apr 15th, 2024 12:00AM Celldex Therapeutics 9.7K 195.00 Open Apr 14th, 2024 10:59PM Apr 15th, 2024 04:27PM Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Open Immuno-oncology, Therapeutic antibodies, Immune system modulators, Immunotherapies, Oncology, Inflammatory Diseases, Inflammation, and Urticaria Open 53 Frontage Road Hampton NJ US 08827 Celldex Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:cldx 597166 Apr 14th, 2024 12:00AM Celldex Therapeutics 9.7K 195.00 Open Apr 13th, 2024 10:48PM Apr 14th, 2024 10:46AM Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Open Immuno-oncology, Therapeutic antibodies, Immune system modulators, Immunotherapies, Oncology, Inflammatory Diseases, Inflammation, and Urticaria Open 53 Frontage Road Hampton NJ US 08827 Celldex Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:cldx 597166 Apr 13th, 2024 12:00AM Celldex Therapeutics 9.7K 195.00 Open Apr 12th, 2024 10:39PM Apr 13th, 2024 11:14AM Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Open Immuno-oncology, Therapeutic antibodies, Immune system modulators, Immunotherapies, Oncology, Inflammatory Diseases, Inflammation, and Urticaria Open 53 Frontage Road Hampton NJ US 08827 Celldex Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:cldx 597166 Apr 12th, 2024 12:00AM Celldex Therapeutics 9.7K 195.00 Open Apr 11th, 2024 10:43PM Apr 12th, 2024 08:09AM Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Open Immuno-oncology, Therapeutic antibodies, Immune system modulators, Immunotherapies, Oncology, Inflammatory Diseases, Inflammation, and Urticaria Open 53 Frontage Road Hampton NJ US 08827 Celldex Therapeutics Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.